Cargando…
Dasatinib synergizes with JSI-124 to inhibit growth and migration and induce apoptosis of malignant human glioma cells
BACKGROUND: Src family kinases (SFK) collectively regulate a variety of cellular functions in many cancer types, including proliferation, invasion, motility, survival, differentiation, and angiogenesis. Although Dasatinib (BMS-354825), an ATP-competitive, small molecule tyrosine kinase inhibitor, su...
Autores principales: | Premkumar, Daniel R., Jane, Esther P., Agostino, Naomi R., Scialabba, Joseph L., Pollack, Ian F. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2924609/ https://www.ncbi.nlm.nih.gov/pubmed/20808823 http://dx.doi.org/10.4103/1477-3163.65448 |
Ejemplares similares
-
JSI-124 Induces Cell Cycle Arrest and Regulates the Apoptosis in Glioblastoma Cells
por: Tsai, Tai-Hsin, et al.
Publicado: (2023) -
JSI-124 Suppresses Invasion and Angiogenesis of Glioblastoma Cells In Vitro
por: Yuan, Guang, et al.
Publicado: (2015) -
Transnational Access to JSI, Slovenia
por: Cindro, V., et al.
Publicado: (2015) -
Dasatinib synergizes with doxorubicin to block growth, migration, and invasion of breast cancer cells
por: Pichot, C S, et al.
Publicado: (2009) -
Cucurbitacin-I (JSI-124) activates the JNK/c-Jun signaling pathway independent of apoptosis and cell cycle arrest in B Leukemic Cells
por: Ishdorj, Ganchimeg, et al.
Publicado: (2011)